GSK2190915 Neutrophilic Asthma Study

NCT01471665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: GSK2190915 100mg
DRUG: Placebo

Sponsor

GlaxoSmithKline